Von Willebrand Disease News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Von Willebrand Disease In Dogs: Symptoms, Causes, & Treatments - DogTime



Von Willebrand Disease In Dogs: Symptoms, Causes, & Treatments 
DogTime
Von Willebrand Disease in dogs is a hereditary bleeding disorder caused by a deficiency of a protein necessary for blood to clot. This protein is known as von Willebrand Factor (vWF), and it is needed for blood platelets to stick together and seal ...

 


Blood Coagulation Factor Market Set to Surge Significantly During 2017?2025 - Digital Journal



Blood Coagulation Factor Market Set to Surge Significantly During 2017?2025 
Digital Journal
Growth in the diagnosis rate of blood clotting diseases such as hemophilia and Von Willebrand disease is also expected to drive the global blood coagulation factor market during the forecast period. According to the data by published The Centers for ...

and more » 


No simple answer for genetic conditions - Toledo Blade



Toledo Blade
 
No simple answer for genetic conditions 
Toledo Blade
Diseases like hypertrophic cardiomyopathy and polycystic kidney disease in cats are examples of autosomal dominant diseases linked to a single genetic mutation. Affected offspring will have some form of the disease and ideally would not be allowed to ...

 


Angioectasia treatment goal is to control the bleeding - Sunbury Daily Item



Angioectasia treatment goal is to control the bleeding 
Sunbury Daily Item
Another is von Willebrand's disease, a common but often-undiagnosed bleeding problem. These would be worth considering, especially in a younger person. The most common location for angiodysplasia to be found in the GI tract is the colon, usually during ...

 


Goal of angioectasia treatment is to control the bleeding - STLtoday.com



Goal of angioectasia treatment is to control the bleeding 
STLtoday.com
Dear Dr. Roach ? I am 40 years old and have been diagnosed with angioectasia of the gastrointestinal tract. From my readings, it seems this is a problem in the elderly. What can I expect with this disease, and what is my prognosis? ? E.C.. Answer ...

and more » 


Shire PLC (LON:SHP) Stock "Hold" Rating Reaffirmed at Liberum ... - Promma News



Shire PLC (LON:SHP) Stock "Hold" Rating Reaffirmed at Liberum ... 
Promma News
Liberum Capital currently has a GBX 4000.00 target on the 31.37B GBP market cap company or 14.60% upside potential. In analysts note sent to investors on 18 January, Shire PLC (LON:SHP) stock had its ?Hold? Rating reaffirmed by expert analysts at ...

and more » 


Biology majors enjoy high-level research opportunities during their undergraduate careers - SCNow



SCNow
 
Biology majors enjoy high-level research opportunities during their undergraduate careers 
SCNow
Fleschner, an aspiring veterinarian, was right at home while researching Von Willebrand disease, an affliction that inhibits proper clotting of a dog's blood. It essentially turns infected dogs into hemophiliacs, which in turn, means minor wounds can ...

 


Shire plc (SHPG) Analysts See $3.89 EPS - Frisco Fastball



Frisco Fastball
 
Shire plc (SHPG) Analysts See $3.89 EPS 
Frisco Fastball
The firm offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. It has a 27.75 P/E ratio. The Company's marketed products include ADVATE and ADYNOVATE ...
Financial Newsletter - Zacks Investment Research Zacks Investment Research

all 151 news articles » 


Von Willebrand Disease. Basic and Clinical Aspects - MilTech



Von Willebrand Disease. Basic and Clinical Aspects 
MilTech
It also reviews the important area of the obstetric and gynecological manifestations of von Willebrand disease, as well as the treatment of acute bleeding. Written by an international team of contributors it describes the progress in, and difficulties ...

 


Analyst at Shore Capital Reiterates Shire Plc (LON:SHP)Stock Rating as a '?Buy?' - Frisco Fastball



Analyst at Shore Capital Reiterates Shire Plc (LON:SHP)Stock Rating as a '?Buy?' 
Frisco Fastball
The firm offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. It has a 20.07 P/E ratio. The Company's marketed products include ADVATE and ADYNOVATE ...
Zacks' 7 Best Strong Buys for 2018 Zacks.com

all 32 news articles »